Status:

COMPLETED

Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo

Lead Sponsor:

Galderma R&D

Conditions:

Rosacea

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to assess relapse, efficacy and safety in subjects with rosacea during long-term treatment with either Oracea® or placebo, after an initial 12-week regimen of Oracea® and ...

Detailed Description

Adult subjects with moderate to severe papulopustular rosacea will receive Oracea® and MetroGel® 1% once daily during phase 1 (baseline to week 12) of the study. Subjects will be eligible to enter pha...

Eligibility Criteria

Inclusion

  • Subject is male or female aged 18 to 80 years inclusive.
  • Subject with papulopustular rosacea (11 to 40 papules or pustules) and an IGA of moderate or severe.
  • For subjects using medications to treat a concurrent medical condition, type and dose must have been stable for at least 90 days prior to study entry.

Exclusion

  • Female subjects who are pregnant, nursing or planning a pregnancy during the study.
  • Subject has any other active dermatological condition on the face that may interfere with the conduct of the study.
  • Subject uses or has recently used any medication which may interfere with the absorption, distribution, or elimination of study medications, or may interfere with the assessments of efficacy or safety of the study medications.
  • Subject has a known allergy to any of the components of the study products, and/or a known hypersensitivity to tetracyclines or metronidazole.

Key Trial Info

Start Date :

September 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2013

Estimated Enrollment :

235 Patients enrolled

Trial Details

Trial ID

NCT01426269

Start Date

September 1 2011

End Date

June 1 2013

Last Update

August 1 2022

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

ATS Clinical Research

Santa Monica, California, United States, 90404

2

Dadeland Dermatology

Coral Gables, Florida, United States, 33134

3

Melissa L. F. Knuckles M.D., P.S.C.

Corbin, Kentucky, United States, 40701

4

Dermatology Specialists Research

Louisville, Kentucky, United States, 40202

Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo | DecenTrialz